Another way Celecoxib could alter Cetuximab efficacy is through the increased expression of EGFR on colon TAFs: in vivo, tumor stroma wrapping epithelial cancer cells could sequester and lower the levels of drug available for cancer targeting. The gene discussed is EGFR; the disease is neoplasm.